Skip to content

Changes in Cerebral Blood Flow in Patients Treated With Spinal Cord Stimulation for Low Back and Leg Pain

Changes in Regional Cerebral Blood Flow as an Indicator of Neuronal Activity in Patients Treated With Spinal Cord Stimulation for Low Back and Leg Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00418301
Enrollment
15
Registered
2007-01-04
Start date
2007-01-31
Completion date
2009-04-30
Last updated
2022-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leg Pain, Low Back Pain, Pain

Keywords

Pain, Neurostimulation

Brief summary

The primary objective of this study is to identify the brain regions in which activity is affected by SCS. Baseline cerebral blood flow scans with the device turned off will be generated compared to scans produced with the device operating at parameters which produce optimal coverage of the painful areas. The relationship between cerebral blood flow and pain rating scores will be evaluated in both conditions.

Detailed description

Spinal Cord Stimulation (SCS) is known to be effective in pain management. Some evidence exists that SCS may cause changes in cerebral blood flow. This study will be a novel PET examination of activity in brain regions affected by SCS. This activity will be compared with the pain intensity and distribution. Further, by examining cerebral blood flow at different doses of stimulation, relationships between SCS, brain perfusion, and pain relief can be drawn. This study will contribute to the elucidation of the mechanism of action of SCS.

Interventions

OTHERPrecision Spinal Cord Stimulation and PET Scan

Imaging procedure to assess spinal Cord Stimulation.

Sponsors

Boston Scientific Corporation
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have had one or more back surgery procedures. * Have used an active Precision SCS device for chronic low back and bilateral leg pain for at least 6 weeks. * Have bilateral leg pain. * Have a baseline VAS of \>4 (without stimulation). * Have greater than 50% reduction in pain with SCS at optimal settings * Be 18 years of age or older. * Have the cognitive and functional capability to operate the controls for the device, to comply with directions during the study, and willing to participate in all study activities. * Be capable of reading and understanding patient information materials and giving written informed consent.

Exclusion criteria

* Have any significant medical condition that is likely to interfere with study procedures or likely to confound evaluation of study endpoints. * Have undergone a surgical lead revision or had any Precision components replaced after initial implantation. * Are allergic to any of the injected media. * Are pregnant or lactating. * Have any contraindication to the PET scan procedure itself or exposure to the intravenous radioactive tracer (H215O). * Have participated in any drug or device trial in the last 4 weeks or are currently participating in another drug or device trial.

Design outcomes

Primary

MeasureTime frame
Cerebral Blood Flow and VAS With Optimal Paresthesia Coverage Compared With SCS OffWithin a few hours

Secondary

MeasureTime frame
Cerebral Blood Flow and VAS With Partial Paresthesia Coverage and Subthreshold Stimulation Compared With Optimal Coverage and With SCS OffWithin a few hours

Countries

United States

Participant flow

Participants by arm

ArmCount
Precision Spinal Cord Stimulation and PET Scan
Positron emission tomography (PET) scan imaging procedures to assess Spinal Cord Stimulation. Precision Spinal Cord Stimulation and PET Scan: Imaging procedure to assess spinal Cord Stimulation.
0
Total0

Baseline characteristics

Characteristic
Region of Enrollment
United States
— participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 15
other
Total, other adverse events
0 / 15
serious
Total, serious adverse events
0 / 15

Outcome results

Primary

Cerebral Blood Flow and VAS With Optimal Paresthesia Coverage Compared With SCS Off

Time frame: Within a few hours

Population: Efforts were made but the information is not accessible at this time. Hence outcome measures are not reported.

Secondary

Cerebral Blood Flow and VAS With Partial Paresthesia Coverage and Subthreshold Stimulation Compared With Optimal Coverage and With SCS Off

Time frame: Within a few hours

Population: Efforts were made but the information is not accessible at this time. Hence outcome measures are not reported.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026